Stocks-AXSM-Axsome Therapeutics Inc

AXSM Axsome Therapeutics Inc

75.26 -2.03 (-2.63%)
Invest
Invest

Overview

Prev Close75.26
Day's Range 73.47 - 77.94
52 Week Range 20.58 - 80.55
Average Volume (3m)1.5M
1-Year Return119.87%
Beta1.1298
Market Cap3.27B
P/E Ratio
Revenue25.67M
EPS-4.0689
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.724/06/202207/09/202216/11/202230.0040.0050.0060.0070.0080.00
Chart times in UTC
Industry Biotechnology
CEO Herriott Tabuteau, MD
Employees 108

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Axsome Therapeutics Inc's revenues decreased by NaN and amounted to 0.00. Net income decreased by 26.73% to -130.40M. Net assets decreased by 65.99% to 38.70M and EPS decreased from -2.77 to -3.47.
AXSM's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
73.66%
Net Profit Margin
N/A
Operating Margin
-597.66%
Return On Investment
-220.57%
12/21
03/22
06/22
09/22
Total Revenue
0
0
8.82M
16.85M
Gross Profit
0
0
7.84M
12.96M
Operating Income
-32.61M
-38.29M
-40.04M
-42.45M
Net Income
-33.98M
-39.63M
-41.44M
-44.82M